Siga(SIGA)
NEW YORK, NYBiotechnology
Focus: Siga is a New York-based biotech company focused on infectious disease treatments, with a lead product in orthopoxvirus antivirals. The company is public (NASDAQ: SIGA) and operates as a lean, focused player in the small-molecule space.
Profile data last refreshed 13h ago · AI intelligence enriched 3w ago
Funding Stage
PUBLIC
Open Jobs
0
About Siga
AI assessmentNot HiringNo open roles listed right now. Follow Siga to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
6/9 — Partial
Company HealthStrong
Pipeline
Late-stage
3 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$140M
Key Products
Peak6.0yr
Lead product generating $140M FY2025 revenue with patent protection extending to 2032; represents core business and cash engine.
Help build intelligence for Siga
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.